Recce Pharmaceuticals Ltd (FRA:R9Q)
Germany flag Germany · Delayed Price · Currency is EUR
0.3500
+0.0300 (9.37%)
At close: Jan 30, 2026

Recce Pharmaceuticals Balance Sheet

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Equivalents
10.454.421.5611.5820.87
Short-Term Investments
0.24----
Cash & Short-Term Investments
10.694.421.5611.5820.87
Cash Growth
142.02%182.74%-86.52%-44.51%678.21%
Other Receivables
0.20.160.090.180.25
Receivables
0.20.160.090.180.25
Other Current Assets
0.50.560.30.420.06
Total Current Assets
11.395.141.9512.1821.18
Property, Plant & Equipment
1.031.230.610.440.5
Other Intangible Assets
00-00
Total Assets
12.416.372.5612.6221.68
Accounts Payable
2.183.970.950.480.49
Accrued Expenses
0.930.570.410.380.39
Short-Term Debt
-9.693.05--
Current Portion of Long-Term Debt
1.53----
Current Portion of Leases
0.220.220.150.070.11
Other Current Liabilities
1.270.620.291.510.09
Total Current Liabilities
6.1315.074.852.451.08
Long-Term Debt
8.6----
Long-Term Leases
0.420.590.1-0.01
Pension & Post-Retirement Benefits
0.320.240.190.120.09
Other Long-Term Liabilities
0-0-0-
Total Liabilities
15.4715.895.142.561.18
Common Stock
81.554.8444.1143.9743.3
Retained Earnings
-91.5-70.08-55.54-42.46-31.47
Comprehensive Income & Other
6.955.718.838.558.68
Shareholders' Equity
-3.05-9.52-2.5910.0620.5
Total Liabilities & Equity
12.416.372.5612.6221.68
Total Debt
10.7710.53.30.070.13
Net Cash (Debt)
-0.08-6.09-1.7411.5120.75
Net Cash Growth
----44.53%698.25%
Net Cash Per Share
-0.00-0.03-0.010.070.13
Filing Date Shares Outstanding
288.37231.61196.83178.02173.78
Total Common Shares Outstanding
288.37203.99178.25177.65173.78
Working Capital
5.26-9.93-2.99.7420.1
Book Value Per Share
-0.01-0.05-0.010.060.12
Tangible Book Value
-3.05-9.52-2.5910.0620.5
Tangible Book Value Per Share
-0.01-0.05-0.010.060.12
Machinery
0.950.920.790.740.62
Source: S&P Global Market Intelligence. Standard template. Financial Sources.